How much does Fluocinolone Acetonide Topical Solution USP, 0.01% cost?

Pricing for Fluocinolone Acetonide Topical Solution USP, 0.01% varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Fluocinolone Acetonide Topical Solution USP, 0.01% need prior authorization?

Fluocinolone Acetonide Topical Solution USP, 0.01% appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Fluocinolone Acetonide Topical Solution USP, 0.01%?

We haven't verified an active copay card or PAP for Fluocinolone Acetonide Topical Solution USP, 0.01% in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Fluocinolone Acetonide Topical Solution USP, 0.01% used to treat?

Fluocinolone Acetonide Topical Solution USP, 0.01% is indicated for Eczema, Corticosteroid-responsive dermatoses. Click any condition name on this page for more detail.

Fluocinolone Acetonide Topical Solution USP, 0.01%

Verified·Apr 23, 2026

NDC: 72162-1271
ICD-10 indication: L30.9

Affordability Check

How much will you actually pay for Fluocinolone Acetonide Topical Solution USP, 0.01%?

In 30 seconds, see every legitimate way to afford Fluocinolone Acetonide Topical Solution USP, 0.01% — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Fluocinolone Acetonide Topical Solution USP, 0.01%

What is this medication? Fluocinolone acetonide topical solution 0.01% is a corticosteroid medication used to treat a variety of skin conditions characterized by inflammation and itching. It is classified as a medium-potency topical steroid that works by activating natural substances in the skin to reduce swelling, redness, and discomfort. This specific liquid formulation is often prescribed for conditions affecting the scalp or other hairy areas of the body, such as seborrheic dermatitis or psoriasis, where traditional creams or heavy ointments might be difficult to apply effectively. The solution works by suppressing the immune response in the localized area and stabilizing cell membranes to prevent the release of chemicals that cause irritation. Patients typically apply a small amount of the liquid to the affected area as directed by their healthcare professional. Because it is a steroid, it should only be used for the duration specified by a doctor to avoid potential side effects like skin thinning. It is intended for external use only and should generally not be used on the face, groin, or underarms unless specifically instructed by a medical provider.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Fluocinolone Acetonide Topical Solution USP, 0.01%.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Fluocinolone Acetonide Topical Solution USP, 0.01% →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Fluocinolone Acetonide Topical Solution USP, 0.01% →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Fluocinolone Acetonide Topical Solution USP, 0.01%. Official source: DailyMed (NLM) · Label effective Feb 18, 2026

Indications and usage

INDICATIONS AND USAGE Fluocinolone Acetonide Topical Solution USP, 0.01% is indicated for the relief of the inﬂammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage and administration

DOSAGE AND ADMINISTRATION Fluocinolone Acetonide Topical Solution USP, 0.01% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. In hairy sites, the hair should be parted to allow direct contact with the lesion. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Contraindications

CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation

Use in pregnancy

Pregnancy Category C Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.